<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Gen Pract</journal-id><journal-id journal-id-type="iso-abbrev">Br J Gen Pract</journal-id><journal-id journal-id-type="publisher-id">bjgp</journal-id><journal-title-group><journal-title>The British Journal of General Practice</journal-title></journal-title-group><issn pub-type="ppub">0960-1643</issn><issn pub-type="epub">1478-5242</issn><publisher><publisher-name>Royal College of General Practitioners</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25179069</article-id><article-id pub-id-type="pmc">4141612</article-id><article-id pub-id-type="doi">10.3399/bjgp14X681361</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Prescribing of nicotine replacement therapy in and around pregnancy: a population-based study using primary care data</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dhalwani</surname><given-names>Nafeesa N</given-names></name><degrees>MSc</degrees><role>Research assistant/data analyst</role></contrib><aff>Division of Primary Care, and doctoral student, Division of Epidemiology and Public Health, University Of Nottingham, Nottingham, UK.</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Szatkowski</surname><given-names>Lisa</given-names></name><degrees>PhD</degrees><role>Lecturer in medical statistics</role></contrib><aff>Division of Epidemiology and Public Health, University Of Nottingham, Nottingham, UK.</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Coleman</surname><given-names>Tim</given-names></name><degrees>MRCGP</degrees><role>Professor of primary care</role></contrib><aff>Division of Primary Care, University Of Nottingham, Nottingham, UK.</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Fiaschi</surname><given-names>Linda</given-names></name><degrees>PhD</degrees><role>Research fellow/data analyst</role></contrib><aff>Division of Epidemiology and Public Health, University Of Nottingham, Nottingham, UK.</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Tata</surname><given-names>Laila J</given-names></name><degrees>PhD</degrees><role>Associate professor in Epidemiology</role></contrib><aff>Division of Epidemiology and Public Health, University Of Nottingham, Nottingham, UK.</aff></contrib-group><author-notes><corresp><bold>Address for correspondence</bold> Nafeesa N Dhalwani, B126, Clinical Sciences Building, City Hospital, Hucknall Road, Nottingham, NG5 1PB, UK. E-mail: <email>nafeesa.dhalwani@nottingham.ac.uk</email></corresp></author-notes><pub-date pub-type="ppub"><month>9</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>01</day><month>9</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>9</month><year>2014</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. --><volume>64</volume><issue>626</issue><fpage>e554</fpage><lpage>e560</lpage><history><date date-type="received"><day>03</day><month>3</month><year>2014</year></date><date date-type="rev-request"><day>01</day><month>4</month><year>2014</year></date><date date-type="accepted"><day>23</day><month>4</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; British Journal of General Practice 2014</copyright-statement><copyright-year>2014</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p><!--CREATIVE COMMONS-->This is an OpenAccess article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background</title><p>Licensing arrangements for nicotine replacement therapy (NRT) in the UK were broadened in 2005 to allow prescribing to pregnant smokers. However, estimates of NRT prescribing in pregnant females in the UK are currently lacking.</p></sec><sec><title>Aim</title><p>To assess trends in NRT prescribing around pregnancy, and variation in prescribing by maternal characteristics.</p></sec><sec><title>Design and setting</title><p>Population-based descriptive study using pregnancy data from The Health Improvement Network primary care database, 2001&#x02013;2012.</p></sec><sec><title>Method</title><p>NRT prescriptions were identified during pregnancy and in the 9 months before and after. Annual prescribing prevalence was calculated. Logistic regression was used to assess females&#x02019; likelihood of receiving prescriptions by maternal characteristics.</p></sec><sec><title>Results</title><p>Of 388 142 pregnancies studied, NRT was prescribed in 7551 for an average duration of 2 weeks. The prescribing prevalence of NRT increased from 0.03% (0.7% in smokers) in 2001 to 2.6% (11.4% in smokers) in 2005, after which it remained stable. Prescribing prevalence of NRT before and after pregnancy was half the prevalence during pregnancy. The odds of prescribing NRT during pregnancy in smokers increased with socioeconomic deprivation (OR = 1.29, 95% CI = 1.15 to 1.45 in the most compared with the least deprived group). Prescribing was 33% higher in pregnant smokers with asthma (OR = 1.33, 95% CI = 1.22 to 1.45) and mental illness (OR = 1.33, 95% CI = 1.23 to 1.44) compared with smokers without these diagnoses.</p></sec><sec><title>Conclusion</title><p>NRT prescribing is higher during pregnancy compared with before and after, and is higher in smokers from more socioeconomically deprived groups, those with asthma or those diagnosed mental illness.</p></sec></abstract><kwd-group><kwd>nicotine replacement therapy</kwd><kwd>pregnancy</kwd><kwd>prescribing</kwd><kwd>smoking cessation</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Smoking in pregnancy is related to several adverse outcomes for both mothers and their children.<xref rid="b1" ref-type="bibr">1</xref>,<xref rid="b2" ref-type="bibr">2</xref> In the UK, 26% of mothers smoke directly before or during their pregnancy, and 12% continue to smoke throughout.<xref rid="b3" ref-type="bibr">3</xref> Similar prevalence has been reported in Australia and the US (11.7% and 10.7% respectively).<xref rid="b4" ref-type="bibr">4</xref>,<xref rid="b5" ref-type="bibr">5</xref> Therefore, reducing smoking in pregnancy is a global public health priority.<xref rid="b6" ref-type="bibr">6</xref></p><p>Nicotine replacement therapy (NRT) is a pharmacological smoking cessation aid which became available on prescription from the UK NHS in April 2001.<xref rid="b7" ref-type="bibr">7</xref> It was initially contraindicated during pregnancy because of a lack of evidence for its safety.<xref rid="b8" ref-type="bibr">8</xref> To date there is no conclusive evidence on its effectiveness during pregnancy,<xref rid="b9" ref-type="bibr">9</xref> and studies of NRT safety during pregnancy are inconclusive.<xref rid="b2" ref-type="bibr">2</xref>,<xref rid="b10" ref-type="bibr">10</xref>&#x02013;<xref rid="b12" ref-type="bibr">12</xref> Nevertheless, expert consensus is that NRT is likely to be less harmful than smoking during pregnancy and, with various caveats, NRT has been recommended by international guidelines when smoking cessation without NRT is unsuccessful.<xref rid="b13" ref-type="bibr">13</xref>&#x02013;<xref rid="b16" ref-type="bibr">16</xref></p><p>Literature describing NRT use in pregnancy is limited to observational studies from the US and Denmark assessing the association of NRT use during pregnancy and adverse birth outcomes. The prevalence of self-reported NRT used in the first 12 weeks of gestation was 0.3%,<xref rid="b17" ref-type="bibr">17</xref> 2&#x02013;2.5% in 17&#x02013;27 weeks of gestation in the Danish National Birth Cohort,<xref rid="b10" ref-type="bibr">10</xref>,<xref rid="b11" ref-type="bibr">11</xref> and in the Pregnancy Risk Assessment Monitoring System (PRAMS) from four US states it was 3.9% (2004).<xref rid="b2" ref-type="bibr">2</xref> Since their publication, new NRT products have been introduced and international guidelines on gestational NRT use have changed. In 2013, the World Health Organization (WHO) recommended an urgent need for studies on the surveillance of current NRT use in pregnancy.<xref rid="b16" ref-type="bibr">16</xref></p><p>In December 2005, UK licensing arrangements were changed to allow prescribing of NRT to pregnant smokers.<xref rid="b18" ref-type="bibr">18</xref> As a result, NRT can now be prescribed to pregnant females by GPs, midwives, or other licensed health professionals working in NHS Stop Smoking Services (SSS) after discussing the risks and benefits of using the drug in pregnancy. Although it can also be bought directly from pharmacies or other retailers such as supermarkets, all drug packaging retains warnings against its use in pregnancy without prior GP consultation. Most NRT is probably received via GP prescription, as half of NRT provided by pregnancy SSSs is issued via the patient&#x02019;s GP.<xref rid="b19" ref-type="bibr">19</xref></p><p>Thus far, only two UK studies have assessed NRT use in pregnancy.<xref rid="b20" ref-type="bibr">20</xref>,<xref rid="b21" ref-type="bibr">21</xref> One of these studies only presents local data from Tayside, Scotland,<xref rid="b21" ref-type="bibr">21</xref> and the second was only among females attending NHS SSS in England.<xref rid="b20" ref-type="bibr">20</xref> Given that only 3% of all pregnant females attend SSSs, this will have excluded most pregnant smokers.<xref rid="b22" ref-type="bibr">22</xref>,<xref rid="b23" ref-type="bibr">23</xref> In this study, UK prescribing of NRT is quantified before, during, and after pregnancy using a nationally representative sample, and the characteristics of females who receive NRT prescriptions are investigated.</p><boxed-text position="float"><sec><title>How this fits in</title><p>Pregnancy is an opportunistic time to offer smoking cessation interventions to females. This study is the first to quantify prescribing of nicotine replacement therapy before, during, and after pregnancy in the UK. Prescribing prevalence of nicotine replacement therapy during pregnancy was 11% among smokers, double the prescribing prevalence before and after pregnancy. However, most females received only 2 weeks of nicotine replacement therapy during pregnancy. Prescribing was higher in pregnant smokers from more deprived areas and in smokers with diagnoses of asthma or mental illness.</p></sec></boxed-text></sec><sec sec-type="methods"><title>METHOD</title><sec sec-type="methods"><title>Data source and study population</title><p>The Health Improvement Network (THIN), an electronic database containing anonymised patient records from general practices across the UK, was used for this study, covering approximately 6% of the population,<xref rid="b24" ref-type="bibr">24</xref> representative of the UK population in terms of demographics, prevalence of common illnesses, and fertility rates.<xref rid="b25" ref-type="bibr">25</xref>,<xref rid="b26" ref-type="bibr">26</xref> Prevalence of smoking and prescribing of smoking cessation medications in the general population in THIN has been validated against national data.<xref rid="b27" ref-type="bibr">27</xref>,<xref rid="b28" ref-type="bibr">28</xref> The study population included all pregnancies between January 2001 and December 2012 in females of childbearing age (15&#x02013;49 years), resulting in a live birth or a stillbirth.</p></sec><sec><title>Outcome and covariates</title><p>The smoking status of females was determined using Read Codes<xref rid="b29" ref-type="bibr">29</xref> recorded from 27 months before conception up to the end of pregnancy, based on the recording rules in the GP contract,<xref rid="b30" ref-type="bibr">30</xref> which is described in detail elsewhere.<xref rid="b31" ref-type="bibr">31</xref> Multilex Drug Codes for all NRT formulations available in the UK according to the <italic>British National Formulary</italic> (<italic>BNF</italic>) were used for NRT prescriptions.<xref rid="b32" ref-type="bibr">32</xref> Code lists are available from the authors on request.</p><p>To investigate factors associated with NRT prescribing, data were extracted on females&#x02019; age at conception, socioeconomic deprivation (Townsend Index),<xref rid="b33" ref-type="bibr">33</xref> preconception body mass index (BMI), and diagnoses of medical conditions (hypertension, diabetes, asthma, and mental illness, which included depression, anxiety, bipolar disorder, schizophrenia, and other psychoses) during or before pregnancy. These conditions were selected as they are closely related to smoking,<xref rid="b3" ref-type="bibr">3</xref>,<xref rid="b34" ref-type="bibr">34</xref>&#x02013;<xref rid="b38" ref-type="bibr">38</xref> and may influence quit attempts.</p></sec><sec sec-type="methods"><title>Statistical analysis</title><p>Overall and annual proportions of pregnancies, and pregnancies among smokers, with one or more NRT prescriptions before, during and after pregnancy were determined. There is no evidence of the time before and after pregnancy during which smokers are more likely to attempt to quit, therefore the 9 months before and after pregnancy were used to calculate prescribing prevalence, as these were similar to the average pregnancy length, allowing for comparisons of period prevalence. As smoking behaviours may fluctuate during a 9-month period, 3-month windows were also assessed during and around pregnancy. The use of different forms of NRT (patches, gum, nasal spray, lozenges, sublingual tablets, inhalator cartridges, and combination) was assessed.</p><p>Logistic regression was used to calculate ORs for associations between females&#x02019; characteristics and prescribing of NRT to smokers during pregnancy, restricting to pregnancies delivered from January 2006, after relaxation of licensing arrangements.<xref rid="b18" ref-type="bibr">18</xref> All covariates reaching statistical significance at the 5% level in univariable models were included in the multivariable analysis and each covariate was sequentially dropped from the model to assess whether it remained statistically significant, retaining only those that were. Some females had more than one pregnancy during the study period and there may be potential clustering of females within practices; this was accounted for by using generalised estimating equations (GEE) with an exchangeable correction structure which provided best estimates of the population-level associations with maternal characteristics despite potential dependence between pregnancy, that is accounting for clustered data.<xref rid="b39" ref-type="bibr">39</xref> Analyses were performed using Stata (version 12.0).</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec sec-type="intro"><title>Baseline characteristics</title><p>Between 2001 and 2012, 388 142 pregnancies were identified resulting in live births or stillbirths, of which 71 685 (18.5%) were in smokers. Mean age at conception was 29.6 years (SD 5.9). <xref ref-type="table" rid="table1">Table 1</xref> describes females&#x02019; characteristics for all pregnancies and pregnancies among smokers, and NRT prescribing according to these characteristics.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><p>Baseline characteristics of the study population</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="center" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1"><bold>Total pregnancies, <italic>n</italic> = 388 142</bold></th><th valign="bottom" align="center" rowspan="1" colspan="1"><bold>NRT prescribed, total <italic>n</italic> = 7551 (% of pregnancies with NRT prescription)</bold></th><th valign="bottom" align="center" rowspan="1" colspan="1"><bold>Pregnancies among smokers,<xref ref-type="table-fn" rid="tfn1"><sup>a</sup></xref><italic>n</italic> = 71 685</bold></th><th valign="bottom" align="center" rowspan="1" colspan="1"><bold>NRT prescribed, <italic>n</italic> = 7551 (% of pregnancies among smokers with NRT prescription)</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Age at conception, years</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">5&#x02013;19</td><td valign="top" align="center" rowspan="1" colspan="1">27 365</td><td valign="top" align="center" rowspan="1" colspan="1">930 (3.4)</td><td valign="top" align="center" rowspan="1" colspan="1">9898</td><td valign="top" align="center" rowspan="1" colspan="1">930 (9.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">20&#x02013;24</td><td valign="top" align="center" rowspan="1" colspan="1">66 484</td><td valign="top" align="center" rowspan="1" colspan="1">1962 (3.0)</td><td valign="top" align="center" rowspan="1" colspan="1">19 849</td><td valign="top" align="center" rowspan="1" colspan="1">1962 (9.9)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">25&#x02013;29</td><td valign="top" align="center" rowspan="1" colspan="1">105 967</td><td valign="top" align="center" rowspan="1" colspan="1">2004 (1.9)</td><td valign="top" align="center" rowspan="1" colspan="1">19 188</td><td valign="top" align="center" rowspan="1" colspan="1">2004 (10.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">30&#x02013;34</td><td valign="top" align="center" rowspan="1" colspan="1">118 031</td><td valign="top" align="center" rowspan="1" colspan="1">1664 (1.4)</td><td valign="top" align="center" rowspan="1" colspan="1">14 534</td><td valign="top" align="center" rowspan="1" colspan="1">1664 (11.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">35&#x02013;39</td><td valign="top" align="center" rowspan="1" colspan="1">59 541</td><td valign="top" align="center" rowspan="1" colspan="1">832 (1.4)</td><td valign="top" align="center" rowspan="1" colspan="1">6952</td><td valign="top" align="center" rowspan="1" colspan="1">832 (12.0)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">40&#x02013;44</td><td valign="top" align="center" rowspan="1" colspan="1">10 222</td><td valign="top" align="center" rowspan="1" colspan="1">152 (1.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1203</td><td valign="top" align="center" rowspan="1" colspan="1">152 (12.6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">45&#x02013;49</td><td valign="top" align="center" rowspan="1" colspan="1">532</td><td valign="top" align="center" rowspan="1" colspan="1">7 (1.3)</td><td valign="top" align="center" rowspan="1" colspan="1">61</td><td valign="top" align="center" rowspan="1" colspan="1">7 (11.5)</td></tr><tr><td colspan="5" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Townsend score in quintiles<xref ref-type="table-fn" rid="tfn2"><sup>b</sup></xref></bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Quintile 1 &#x02013; most affluent</td><td valign="top" align="center" rowspan="1" colspan="1">83 203</td><td valign="top" align="center" rowspan="1" colspan="1">722 (0.9)</td><td valign="top" align="center" rowspan="1" colspan="1">7970</td><td valign="top" align="center" rowspan="1" colspan="1">722 (9.1)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Quintile 2</td><td valign="top" align="center" rowspan="1" colspan="1">71 045</td><td valign="top" align="center" rowspan="1" colspan="1">925 (1.3)</td><td valign="top" align="center" rowspan="1" colspan="1">9511</td><td valign="top" align="center" rowspan="1" colspan="1">925 (9.7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Quintile 3</td><td valign="top" align="center" rowspan="1" colspan="1">76 619</td><td valign="top" align="center" rowspan="1" colspan="1">1432 (1.9)</td><td valign="top" align="center" rowspan="1" colspan="1">14 291</td><td valign="top" align="center" rowspan="1" colspan="1">1432 (10.0)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Quintile 4</td><td valign="top" align="center" rowspan="1" colspan="1">73 470</td><td valign="top" align="center" rowspan="1" colspan="1">2068 (2.8)</td><td valign="top" align="center" rowspan="1" colspan="1">18 097</td><td valign="top" align="center" rowspan="1" colspan="1">2068 (11.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Quintile 5 &#x02013; most deprived</td><td valign="top" align="center" rowspan="1" colspan="1">55 653</td><td valign="top" align="center" rowspan="1" colspan="1">1875 (3.4)</td><td valign="top" align="center" rowspan="1" colspan="1">16 925</td><td valign="top" align="center" rowspan="1" colspan="1">1875 (11.1)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Missing</td><td valign="top" align="center" rowspan="1" colspan="1">28 152</td><td valign="top" align="center" rowspan="1" colspan="1">529 (1.9)</td><td valign="top" align="center" rowspan="1" colspan="1">4891</td><td valign="top" align="center" rowspan="1" colspan="1">529 (10.8)</td></tr><tr><td colspan="5" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Pre-conception body mass index, kg/m<sup>2</sup></bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Normal (18.0&#x02013;24.9)</td><td valign="top" align="center" rowspan="1" colspan="1">118 832</td><td valign="top" align="center" rowspan="1" colspan="1">2266 (1.9)</td><td valign="top" align="center" rowspan="1" colspan="1">22 888</td><td valign="top" align="center" rowspan="1" colspan="1">2266 (9.9)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Underweight (&#x0003c;18.0)</td><td valign="top" align="center" rowspan="1" colspan="1">8614</td><td valign="top" align="center" rowspan="1" colspan="1">256 (3.0)</td><td valign="top" align="center" rowspan="1" colspan="1">2353</td><td valign="top" align="center" rowspan="1" colspan="1">256 (10.9)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Overweight (25&#x02013;29.9)</td><td valign="top" align="center" rowspan="1" colspan="1">58 693</td><td valign="top" align="center" rowspan="1" colspan="1">1237 (2.1)</td><td valign="top" align="center" rowspan="1" colspan="1">11 464</td><td valign="top" align="center" rowspan="1" colspan="1">1237 (10.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Obese (&#x02265;30)</td><td valign="top" align="center" rowspan="1" colspan="1">42 281</td><td valign="top" align="center" rowspan="1" colspan="1">992 (2.3)</td><td valign="top" align="center" rowspan="1" colspan="1">9191</td><td valign="top" align="center" rowspan="1" colspan="1">992 (10.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Missing</td><td valign="top" align="center" rowspan="1" colspan="1">159 722</td><td valign="top" align="center" rowspan="1" colspan="1">2800 (1.8)</td><td valign="top" align="center" rowspan="1" colspan="1">25 789</td><td valign="top" align="center" rowspan="1" colspan="1">2800 (10.9)</td></tr><tr><td colspan="5" valign="middle" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Asthma</bold></td><td valign="top" align="center" rowspan="1" colspan="1">33 724</td><td valign="top" align="center" rowspan="1" colspan="1">1061 (3.1)</td><td valign="top" align="center" rowspan="1" colspan="1">8188</td><td valign="top" align="center" rowspan="1" colspan="1">1061 (13.0)</td></tr><tr><td colspan="5" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Hypertension</bold></td><td valign="top" align="center" rowspan="1" colspan="1">9992</td><td valign="top" align="center" rowspan="1" colspan="1">154 (1.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1420</td><td valign="top" align="center" rowspan="1" colspan="1">154 (10.8)</td></tr><tr><td colspan="5" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Diabetes</bold></td><td valign="top" align="center" rowspan="1" colspan="1">10 752</td><td valign="top" align="center" rowspan="1" colspan="1">224 (2.1)</td><td valign="top" align="center" rowspan="1" colspan="1">1798</td><td valign="top" align="center" rowspan="1" colspan="1">224 (12.5)</td></tr><tr><td colspan="5" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Mental illness</bold></td><td valign="top" align="center" rowspan="1" colspan="1">37 055</td><td valign="top" align="center" rowspan="1" colspan="1">1547 (4.2)</td><td valign="top" align="center" rowspan="1" colspan="1">11 624</td><td valign="top" align="center" rowspan="1" colspan="1">1547 (13.3)</td></tr></tbody></table><table-wrap-foot><fn id="tfn1"><label>a</label><p>Smoker classified as those with a record of current smoking at some point within the 27 months before conception until delivery.</p></fn><fn id="tfn2"><label>b</label><p>Socioeconomic status. NRT = nicotine replacement therapy.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Patterns of NRT prescribing in and around pregnancy</title><p>NRT was prescribed in 7551 pregnancies, which represented a prescribing prevalence of 2% of all pregnancies and 11% of pregnancies in smokers. In comparison, the prescribing prevalence was 1% during the 9 months before and after pregnancy overall, and 5% in smokers. <xref ref-type="fig" rid="fig1">Figure 1</xref> shows the prescribing prevalence in 3-month periods outside pregnancy and by trimester. NRT prescribing among smokers was most frequent during the first and second trimesters at just over 5%, compared with 2% in the third trimester.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><p><bold><italic>Proportion of overall pregnancies and smokers with NRT prescriptions in each 3-month time period, between 2001 and 2012.</italic></bold></p></caption><graphic xlink:href="bjgpSep-2014-64-626-456-1"/></fig><p>Among the pregnancies where NRT was prescribed, over half (55%) had only one prescription issued, 25% had two prescriptions, and 20% had three or more prescriptions. The maximum number of prescriptions issued during pregnancy was 26. On average, females were prescribed a total of 2 weeks&#x02019; worth of NRT (interquartile range 1&#x02013;2 weeks). The prescription frequency and length of NRT issued in the 9 months before and after pregnancy was similar to pregnancy time.</p><p>In two-thirds of the pregnancies in which NRT was prescribed, it was initiated only during pregnancy, with no evidence of NRT prescribing prior to the start of pregnancy. The most common form of NRT used during pregnancy was transdermal patches (65% of all prescriptions), followed by inhalator cartridges (17%), gum (8%), lozenges (6%), sublingual tablets (2%), oromucosal spray (0.7%), and nasal spray (0.3%). Combination NRT was used in 14% of pregnancies where NRT was prescribed. The distribution of NRT forms prescribed before and after pregnancy was very similar.</p></sec><sec><title>Annual prescribing of NRT before, during, and after pregnancy</title><p><xref ref-type="fig" rid="fig2">Figure 2</xref> shows the proportion of pregnancies between 2001 and 2012 in which NRT was prescribed before, during, and after pregnancy. In 2001, the prescribing prevalence of NRT in all pregnancies during gestation was 0.03% (0.7% of pregnancies among smokers). This increased to 2.6% (11.4% among smokers) in 2005, after which it remained stable. The proportion of pregnancies with NRT prescriptions issued in the 9 months before and after pregnancy increased until 2004, after which it remained stable at around 1% (6% among smokers) with a gradual decline in prescribing prevalence after 2006.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><p><bold><italic>Annual prescribing prevalence of NRT between 2001 and 2012.</italic></bold></p></caption><graphic xlink:href="bjgpSep-2014-64-626-456-2"/></fig></sec><sec sec-type="intro"><title>Prescribing of NRT by maternal characteristics</title><p><xref ref-type="table" rid="table2">Table 2</xref> shows the maternal characteristics associated with prescribing in pregnant smokers between 2006 and 2012. Prescribing was higher in older compared with younger age groups (OR for 40&#x02013;44 years = 1.27, 95% CI = 1.03 to 1.58, compared with the 25&#x02013;29-year age group). Pregnant smokers from more socioeconomically deprived groups were more likely to receive prescriptions compared with less deprived groups (OR for quintile 5 compared with quintile 1 = 1.29, 95% CI = 1.15 to 1.45). Pregnant smokers with a diagnosis of asthma or mental illness were 33% more likely to be prescribed compared with pregnant smokers without these morbidities.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><p>Prescribing of NRT in pregnant smokers by maternal characteristics between January 2006 and December 2012</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1"><bold>Demographic variables</bold></th><th valign="bottom" align="center" rowspan="1" colspan="1"><bold>Pregnancies among smokers with one or more NRT prescriptions, <italic>n</italic> = 5756,<xref ref-type="table-fn" rid="tfn4"><sup>a</sup></xref><italic>n</italic> (%)</bold></th><th valign="bottom" align="center" rowspan="1" colspan="1"><bold>Unadjusted odds ratio (95% CI)</bold></th><th valign="bottom" align="center" rowspan="1" colspan="1"><bold><italic>P</italic>- value</bold></th><th valign="bottom" align="center" rowspan="1" colspan="1"><bold>Adjusted odds ratio (95% CI)<xref ref-type="table-fn" rid="tfn5"><sup>b</sup></xref></bold></th><th valign="bottom" align="center" rowspan="1" colspan="1"><bold><italic>P</italic>- value</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Age at conception, years</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">15&#x02013;19</td><td valign="top" align="center" rowspan="1" colspan="1">721 (9.9)</td><td valign="top" align="center" rowspan="1" colspan="1">0.92 (0.84 to 1.01)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.93 (0.84 to 1.03)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">20&#x02013;24</td><td valign="top" align="center" rowspan="1" colspan="1">1533 (10.2)</td><td valign="top" align="center" rowspan="1" colspan="1">0.94 (0.88 to 1.02)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td valign="top" align="center" rowspan="1" colspan="1">0.93 (0.86 to 1.00)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">25&#x02013;29</td><td valign="top" align="center" rowspan="1" colspan="1">1537 (10.7)</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">30&#x02013;34</td><td valign="top" align="center" rowspan="1" colspan="1">1222 (11.9)</td><td valign="top" align="center" rowspan="1" colspan="1">1.12 (1.04 to 1.22)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.13 (1.04 to 1.23)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">35&#x02013;39</td><td valign="top" align="center" rowspan="1" colspan="1">616 (12.2)</td><td valign="top" align="center" rowspan="1" colspan="1">1.16 (1.05 to 1.28)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.17 (1.05 to 1.30)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">40&#x02013;44</td><td valign="top" align="center" rowspan="1" colspan="1">122 (13.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1.28 (1.05 to 1.56)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.27 (1.03 to 1.58)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">45&#x02013;49</td><td valign="top" align="center" rowspan="1" colspan="1">5 (10.9)</td><td valign="top" align="center" rowspan="1" colspan="1">1.01 (0.40 to 2.58)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.12 (0.43 to 2.96)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td colspan="6" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Townsend score</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Quintile 1 (least deprived)</td><td valign="top" align="center" rowspan="1" colspan="1">505 (9.2)</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Quintile 2</td><td valign="top" align="center" rowspan="1" colspan="1">696 (10.1)</td><td valign="top" align="center" rowspan="1" colspan="1">1.10 (0.98 to 1.25)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<xref ref-type="table-fn" rid="tfn6"><sup>c</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">1.09 (0.96 to 1.24)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<xref ref-type="table-fn" rid="tfn6"><sup>c</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Quintile 3</td><td valign="top" align="center" rowspan="1" colspan="1">1101 (10.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1.14 (1.01 to 1.27)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.19 (1.05 to 1.34)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Quintile 4</td><td valign="top" align="center" rowspan="1" colspan="1">1605 (11.8)</td><td valign="top" align="center" rowspan="1" colspan="1">1.35 (1.19 to 1.48)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.37 (1.22 to 1.54)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Quintile 5 (most deprived)</td><td valign="top" align="center" rowspan="1" colspan="1">1428 (11.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1.25 (1.13 to 1.39)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.29 (1.15 to 1.45)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Missing</td><td valign="top" align="center" rowspan="1" colspan="1">421 (11.4)</td><td valign="top" align="center" rowspan="1" colspan="1">1.27 (1.10 to 1.45)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.33 (1.15 to 1.54)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td colspan="6" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Pre-conception body mass index, kg/m<sup>2</sup></bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Underweight</td><td valign="top" align="center" rowspan="1" colspan="1">206 (11.0)</td><td valign="top" align="center" rowspan="1" colspan="1">1.12 (0.96 to 1.30)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Normal</td><td valign="top" align="center" rowspan="1" colspan="1">1786 (10.6)</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="center" rowspan="1" colspan="1">0.414</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Overweight</td><td valign="top" align="center" rowspan="1" colspan="1">976 (11.2)</td><td valign="top" align="center" rowspan="1" colspan="1">1.06 (0.97 to 1.14)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Obese</td><td valign="top" align="center" rowspan="1" colspan="1">806 (11.1)</td><td valign="top" align="center" rowspan="1" colspan="1">1.06 (0.96 to 1.15)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Missing</td><td valign="top" align="center" rowspan="1" colspan="1">1982 (10.8)</td><td valign="top" align="center" rowspan="1" colspan="1">1.02 (0.95 to 1.09)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td colspan="6" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Diabetes</bold></td><td valign="top" align="center" rowspan="1" colspan="1">193 (13.2)</td><td valign="top" align="center" rowspan="1" colspan="1">1.26 (1.08 to 1.47)</td><td valign="top" align="center" rowspan="1" colspan="1">0.075</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td colspan="6" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Hypertension</bold></td><td valign="top" align="center" rowspan="1" colspan="1">114 (11.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1.04 (0.86 to 1.27)</td><td valign="top" align="center" rowspan="1" colspan="1">0.660</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td colspan="6" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Asthma</bold></td><td valign="top" align="center" rowspan="1" colspan="1">845 (13.8)</td><td valign="top" align="center" rowspan="1" colspan="1">1.36 (1.26 to 1.48)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td valign="top" align="center" rowspan="1" colspan="1">1.33 (1.22 to 1.45)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td colspan="6" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Mental illness</bold></td><td valign="top" align="center" rowspan="1" colspan="1">1181 (13.7)</td><td valign="top" align="center" rowspan="1" colspan="1">1.38 (1.29 to 1.48)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td valign="top" align="center" rowspan="1" colspan="1">1.33 (1.23 to 1.44)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn id="tfn3"><p>NRT = nicotine replacement therapy.</p></fn><fn id="tfn4"><label>a</label><p>Percentages of pregnancies in smokers with NRT prescription.</p></fn><fn id="tfn5"><label>b</label><p>All covariates mutually adjusted.</p></fn><fn id="tfn6"><label>c</label><p>P<italic>-value for trend.</italic></p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><sec sec-type="conclusions"><title>Summary</title><p>After NRT was made available on NHS prescription in 2001, prescribing in and around pregnancy increased; by 2005 prescribing was twice as high during pregnancy as in the 9 months immediately before and after pregnancy, despite being contraindicated for pregnant females. The December 2005 licence relaxation to allow prescribing in pregnancy did not further increase these trends and the prescribing prevalence during pregnancy has remained stable at 2% (11% in smokers). Females with asthma or mental illnesses and those from more socioeconomically-deprived areas were more likely to receive prescriptions during pregnancy. Eighty per cent of females received &#x02264;2 prescriptions.</p></sec><sec><title>Strengths and limitations</title><p>Using a large population-based data source, longitudinal and contemporaneous prescribing estimates are presented; this is the first study of NRT prescribing during pregnancy in the UK and the only study internationally that has assessed prescribing trends. Ascertainment of NRT use is based on prescribing data rather than self-reported NRT use, which females may under-report.<xref rid="b11" ref-type="bibr">11</xref> Prescribing in 9-month periods immediately before and after pregnancy was also assessed, whereas other studies only report NRT use in trimesters one and two.<xref rid="b10" ref-type="bibr">10</xref>,<xref rid="b11" ref-type="bibr">11</xref>,<xref rid="b17" ref-type="bibr">17</xref> Therefore, the present estimates of NRT prescribing around pregnancy are novel in providing population-level information on smoking cessation attempts pre-conception and postpartum for the first time.</p><p>The present study data capture all NRT prescribing to pregnant females in UK primary care in practices registered in THIN. These data may not include NRT prescribing in other settings such as local NHS Stop Smoking Services for Pregnant females (SSSP) and NRT purchased in pharmacies or retailers. A survey of all SSSPs in England conducted between April 2010 and March 2011 reported that almost half of the NRT provided by these services was issued through GPs.<xref rid="b40" ref-type="bibr">40</xref> In terms of self-purchased NRT, the authors believe this will be infrequent for several reasons. Firstly, the prevalence of medication use without health professional consultation is lower during pregnancy than when females are not pregnant.<xref rid="b41" ref-type="bibr">41</xref> Furthermore, all packages of NRT clearly instruct females to consult a doctor before using them if they are pregnant. Lastly, in the UK females are entitled to free NHS prescriptions during pregnancy,<xref rid="b42" ref-type="bibr">42</xref> so they are more likely to get free prescriptions through GPs than paying for NRT. Hence, the authors believe that this study captures most prescriptions of NRT issued and provides valuable information on prescribing patterns during pregnancy.</p><p>Potential changes in smoking habits were not accounted for over the study, and therefore this study has also presented proportions for all pregnancies. Some females may quit or relapse after delivery consequently leading to changes in the baseline smokers; NRT estimates could therefore be overestimated if more females relapse than are recorded, and underestimated if more females quit. In the present data, however, over 75% of pregnant females who were classified as smokers during pregnancy and who had a recording of smoking status within the 9 months after delivery were still recorded as smokers. Therefore, a substantial overestimation or underestimation is unlikely.</p></sec><sec><title>Comparison with existing literature</title><p>The present study data suggest that UK prescribing of NRT during pregnancy increased between 2001 and 2005, after which it plateaued. Despite NRT use being recommended in smoking cessation guidelines for pregnant females in several countries,<xref rid="b14" ref-type="bibr">14</xref>,<xref rid="b15" ref-type="bibr">15</xref>,<xref rid="b18" ref-type="bibr">18</xref> no other studies thus far have assessed the annual prescribing prevalence of NRT during pregnancy for comparison. Studies from the US, Denmark, and Scotland report an overall prescribing prevalence of between 0.3% and 4%.<xref rid="b2" ref-type="bibr">2</xref>,<xref rid="b10" ref-type="bibr">10</xref>,<xref rid="b11" ref-type="bibr">11</xref>,<xref rid="b21" ref-type="bibr">21</xref> NRT use in pregnant smokers attending English SSSs is reported to be 85%<xref rid="b20" ref-type="bibr">20</xref> and considering that only 3% of pregnant females attend these services, this equates to 2.5%, which is similar to the present findings.</p><p>The National Institute for Health and Care Excellence (NICE) recommends that pregnant females should initially be prescribed 2 weeks of NRT from their agreed stop date with further NRT after re-assessment.<xref rid="b7" ref-type="bibr">7</xref> The average duration of prescription for females in the present study was 2 weeks and most females (80%) received two or fewer prescriptions. One reason for this may be that compliance was low and females did not quit or use it to quit, in which case no further NRT was prescribed. Some females may have bought NRT independently after the first prescription; however, considering that females are entitled to free prescriptions during pregnancy and NRT from retailers is reasonably expensive, this is unlikely. Studies in other populations have not reported the duration of NRT use in pregnancy. However, 8&#x02013;12 weeks&#x02019; use is recommended for optimal effectiveness in the general population,<xref rid="b43" ref-type="bibr">43</xref> so it is unlikely that 2 weeks&#x02019; use is effective for smoking cessation in pregnancy.</p><p>A study including 5716 pregnant females from the US showed NRT prescribing to be lower in pregnant smokers aged &#x0003c;35 years compared with pregnant smokers aged &#x02265;35 years,<xref rid="b2" ref-type="bibr">2</xref> which is similar to the present findings. Low socioeconomic status is associated with a higher prevalence of chronic disease<xref rid="b44" ref-type="bibr">44</xref> and higher risk of adverse pregnancy outcomes,<xref rid="b45" ref-type="bibr">45</xref> which could explain why pregnant smokers in the deprived group in this study were prescribed NRT more often than affluent groups. Asthma and mental illness are the most common medical conditions encountered during pregnancy,<xref rid="b46" ref-type="bibr">46</xref>,<xref rid="b47" ref-type="bibr">47</xref> and are closely related to smoking, which may explain the significant association with NRT prescribing compared with other conditions.</p><p>The English SSSPs study reported that 55% of all pregnant smokers (65% of pregnant NRT users) used combination NRT,<xref rid="b20" ref-type="bibr">20</xref> which is high compared with the present estimate of 14%. This is mostly likely related to different baseline populations. Females voluntarily attending these specialist services likely have a higher motivation to quit, which may result in more quit attempts and more NRT being prescribed compared with females attending primary care.</p><p>It is unfortunate that NRT prescribing prevalence outside pregnancy began to decline considering the demonstrated effectiveness of NRT;<xref rid="b48" ref-type="bibr">48</xref> however, this may be related to the licensing of varenicline for smoking cessation in the non-pregnant population in December 2006, after which a reduction in NRT and bupropion prescribing was seen in the general population.<xref rid="b49" ref-type="bibr">49</xref></p></sec><sec sec-type="discussion"><title>Implications for practice</title><p>Pregnancy offers a strategic opportunity for health professionals to promote smoking cessation as females are generally more receptive to cessation interventions and are more likely to attempt to quit smoking because of the potential foetal harm associated with smoking during pregnancy.<xref rid="b50" ref-type="bibr">50</xref> The study findings give insight into the prescribing in and around pregnancy, which is important for policy makers and GPs to monitor and promote smoking cessation in females of childbearing age. The study shows that NRT was prescribed for an average of only 2 weeks during pregnancy, which is unlikely to be effective considering that NRT use in the general population for smoking cessation is recommended for at least 8&#x02013;12 weeks. It is also highlighted that only 1% of smokers who are not yet pregnant receive NRT, which indicates missed opportunities to assist young females to quit, despite the reported effectiveness of NRT outside pregnancy. Although interactions between health professionals and females during pregnancy should be used to discuss and offer interventions to promote smoking cessation, greater potential benefit would result from starting before pregnancy which should be a prioritised focus for females and healthcare providers.</p></sec></sec></body><back><notes><sec><title>Funding</title><p>This work is supported by a University of Nottingham International Research Excellence Scholarship and the National Institute for Health Research (NIHR). This article presents independent research funded by the NIHR under its Programme Grants for Applied Research Programme (reference RP-PG 0109-10020). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. Nafeesa N Dhalwani, Lisa Szatkowski and Tim Coleman are members of the UK Centre for Tobacco and Alcohol Studies (UKCTAS) (<ext-link ext-link-type="uri" xlink:href="http://www.ukctas.ac.uk">http://www.ukctas.ac.uk</ext-link>). Funding from the BHF, Cancer Research UK, the Economic and Social Research Council, the Medical Research Council and the NIHR, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></sec><sec><title>Ethical approval</title><p>Ethical approval for this study was obtained from the THIN Scientific Review Committee (reference number 11-047).</p></sec><sec><title>Provenance</title><p>Freely submitted; externally peer reviewed.</p></sec><sec><title>Competing interests</title><p>Tim Coleman was paid to attend a symposium arranged by Pierre Fabre Laboratories, France in 2012. The other authors have declared no competing interests.</p></sec><sec><title>Discuss this article</title><p>Contribute and read comments about this article: <bold><ext-link ext-link-type="uri" xlink:href="www.bjgp.org/letters">www.bjgp.org/letters</ext-link></bold></p></sec></notes><ref-list><title>REFERENCES</title><ref id="b1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neuman</surname><given-names>A</given-names></name><name><surname>Hohmann</surname><given-names>C</given-names></name><name><surname>Orsini</surname><given-names>N</given-names></name><etal/></person-group><article-title>Maternal smoking in pregnancy and asthma in preschool children</article-title><source>Am J Respir Crit Care Med</source><year>2012</year><volume>186</volume><issue>10</issue><fpage>1037</fpage><lpage>1043</lpage><pub-id pub-id-type="pmid">22952297</pub-id></element-citation></ref><ref id="b2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaither</surname><given-names>KH</given-names></name><name><surname>Brunner Huber</surname><given-names>LR</given-names></name><name><surname>Thompson</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Does the use of nicotine replacement therapy during pregnancy affect pregnancy outcomes?</article-title><source>Matern Child Health J</source><year>2009</year><volume>13</volume><issue>4</issue><fpage>497</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">18478321</pub-id></element-citation></ref><ref id="b3"><label>3.</label><element-citation publication-type="book"><article-title>Health and Social Care Information Centre</article-title><source>The infant feeding survey 2010: early results</source><year>2011</year><publisher-loc>York</publisher-loc><publisher-name>The NHS Information Centre</publisher-name></element-citation></ref><ref id="b4"><label>4.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Scollo</surname><given-names>M</given-names></name><name><surname>Winstanlet</surname><given-names>M</given-names></name></person-group><source>Tobacco in Australia: facts and issues</source><year>2012</year><publisher-loc>Melbourne</publisher-loc><publisher-name>Cancer Council Victoria</publisher-name></element-citation></ref><ref id="b5"><label>5.</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Centers for Disease Control and Prevention</collab></person-group><source>Prevalence of Smoking during the last 3 months of Pregnancy, PRAMS, 2000&#x02013;2008</source><comment><ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/prams/DATA-TobaccoTables.htm#table2">http://www.cdc.gov/prams/DATA-TobaccoTables.htm#table2</ext-link> (accessed 9 Jul 2014)</comment></element-citation></ref><ref id="b6"><label>6.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Report on the Global Tobacco Epidemic 2008 &#x02014; the mpower package</source><year>2008</year><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></element-citation></ref><ref id="b7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>National Institute for Health and Care Excellence</collab></person-group><source>Quitting smoking in pregnancy and following childbirth</source><year>2010</year><comment>NICE guidelines [PH26]. <ext-link ext-link-type="uri" xlink:href="http://guidance.nice.org.uk/PH26/Guidance/pdf/English">http://guidance.nice.org.uk/PH26/Guidance/pdf/English</ext-link> (accessed 9 Jul 2014)</comment></element-citation></ref><ref id="b8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>T</given-names></name><name><surname>Chamberlain</surname><given-names>C</given-names></name><name><surname>Cooper</surname><given-names>S</given-names></name><etal/></person-group><article-title>Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: systematic review and meta-analysis</article-title><source>Addiction</source><year>2011</year><volume>106</volume><issue>1</issue><fpage>52</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">21054620</pub-id></element-citation></ref><ref id="b9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>T</given-names></name><name><surname>Cooper</surname><given-names>S</given-names></name><name><surname>Thornton</surname><given-names>JG</given-names></name><etal/></person-group><article-title>A randomized trial of nicotine-replacement therapy patches in pregnancy</article-title><source>N Engl J Med</source><year>2012</year><volume>366</volume><issue>9</issue><fpage>808</fpage><lpage>818</lpage><pub-id pub-id-type="pmid">22375972</pub-id></element-citation></ref><ref id="b10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lassen</surname><given-names>TH</given-names></name><name><surname>Madsen</surname><given-names>M</given-names></name><name><surname>Skovgaard</surname><given-names>LT</given-names></name><etal/></person-group><article-title>Maternal use of nicotine replacement therapy during pregnancy and offspring birthweight: a study within the Danish National Birth Cohort</article-title><source>Paediatr Perinat Epidemiol</source><year>2010</year><volume>24</volume><issue>3</issue><fpage>272</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">20415757</pub-id></element-citation></ref><ref id="b11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strandberg-Larsen</surname><given-names>K</given-names></name><name><surname>Tinggaard</surname><given-names>M</given-names></name><name><surname>Andersen</surname><given-names>AN</given-names></name><etal/></person-group><article-title>Use of nicotine replacement therapy during pregnancy and stillbirth: a cohort study</article-title><source>Br J Obstet Gynaecol</source><year>2008</year><volume>115</volume><issue>11</issue><fpage>1405</fpage><lpage>1410</lpage></element-citation></ref><ref id="b12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>T</given-names></name><name><surname>Chamberlain</surname><given-names>C</given-names></name><name><surname>Davey</surname><given-names>M-A</given-names></name><etal/></person-group><article-title>Pharmacological interventions for promoting smoking cessation during pregnancy</article-title><source>Cochrane Database Syst Rev</source><year>2012</year><volume>9</volume><fpage>CD010078</fpage><pub-id pub-id-type="pmid">22972148</pub-id></element-citation></ref><ref id="b13"><label>13.</label><element-citation publication-type="book"><article-title>Medicines and Healthcare products Regulatory Agency</article-title><source>Report of the committee on safety of medicines working group on nicotine replacement therapy</source><year>2005</year><publisher-loc>London</publisher-loc><publisher-name>Medicines and Healthcare products Regulatory Authority</publisher-name></element-citation></ref><ref id="b14"><label>14.</label><element-citation publication-type="book"><article-title>European Network for Smoking and Tobacco Prevention</article-title><source>European Smoking Cessation Guidelines: the authoritative guide to a comprehensive understanding of the implications and implementation of treatments and strategies to treat tobacco dependence</source><year>2011</year><publisher-loc>Brussels</publisher-loc><publisher-name>European Network for Smoking and Tobacco Prevention aisbl (ENSP)</publisher-name></element-citation></ref><ref id="b15"><label>15.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Zwar</surname><given-names>N</given-names></name><name><surname>Richmond</surname><given-names>R</given-names></name><name><surname>Borland</surname><given-names>R</given-names></name><etal/></person-group><source>Supporting smoking cessation: a guide for health professionals</source><year>2011</year><publisher-loc>Melbourne</publisher-loc><publisher-name>The Royal Australian College of General Practitioners</publisher-name></element-citation></ref><ref id="b16"><label>16.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>WHO recommendations for the prevention and management of tobacco use and second-hand exposure in pregnancy</source><year>2013</year><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></element-citation></ref><ref id="b17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales-Suarez-Varela</surname><given-names>MM</given-names></name><name><surname>Bille</surname><given-names>C</given-names></name><name><surname>Christensen</surname><given-names>K</given-names></name><etal/></person-group><article-title>Smoking habits, nicotine use, and congenital malformations</article-title><source>Obstet Gynecol</source><year>2006</year><volume>107</volume><issue>1</issue><fpage>51</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">16394039</pub-id></element-citation></ref><ref id="b18"><label>18.</label><element-citation publication-type="book"><article-title>Action on Smoking and Health</article-title><source>Nicotine replacement therapy &#x02014; guidance for health professionals on changes in the licensing arrangements for nicotine replacement therapy</source><year>2005</year><publisher-loc>London</publisher-loc><publisher-name>ASH</publisher-name></element-citation></ref><ref id="b19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fahy</surname><given-names>SJ</given-names></name><name><surname>Cooper</surname><given-names>S</given-names></name><name><surname>Coleman</surname><given-names>T</given-names></name><etal/></person-group><article-title>Provision of smoking cessation support for pregnant women in England: results from an online survey of NHS stop smoking services for pregnant women</article-title><source>BMC Health Serv Res</source><year>2014</year><volume>14</volume><issue>1</issue><fpage>107</fpage><pub-id pub-id-type="pmid">24593130</pub-id></element-citation></ref><ref id="b20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brose</surname><given-names>LS</given-names></name><name><surname>McEwen</surname><given-names>A</given-names></name><name><surname>West</surname><given-names>R</given-names></name></person-group><article-title>Association between nicotine replacement therapy use in pregnancy and smoking cessation</article-title><source>Drug Alcohol Depend</source><year>2013</year><volume>132</volume><issue>3</issue><fpage>660</fpage><lpage>664</lpage><pub-id pub-id-type="pmid">23680076</pub-id></element-citation></ref><ref id="b21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irvine</surname><given-names>L</given-names></name><name><surname>Flynn</surname><given-names>RW</given-names></name><name><surname>Libby</surname><given-names>G</given-names></name><etal/></person-group><article-title>Drugs dispensed in primary care during pregnancy</article-title><source>Drug Saf</source><year>2010</year><volume>33</volume><issue>7</issue><fpage>593</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">20553060</pub-id></element-citation></ref><ref id="b22"><label>22.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>National Audit Office, Department of Health</collab></person-group><source>Maternity services in England</source><year>2013</year><publisher-loc>London</publisher-loc><publisher-name>The Stationery Office</publisher-name></element-citation></ref><ref id="b23"><label>23.</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Health and Social Care Information Centre</collab></person-group><article-title>NHS Stop Smoking Services: England, April 2012 to December 2012 (Q3&#x02013; Quarterly report)</article-title><comment><ext-link ext-link-type="uri" xlink:href="http://www.hscic.gov.uk/catalogue/PUB10693">http://www.hscic.gov.uk/catalogue/PUB10693</ext-link> (accessed 29 Jul 2014)</comment></element-citation></ref><ref id="b24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>CSD Medical Research UK</collab></person-group><source>THIN Data Guide for Researchers</source><year>2011</year></element-citation></ref><ref id="b25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blak</surname><given-names>BT</given-names></name><name><surname>Thompson</surname><given-names>M</given-names></name><name><surname>Dattani</surname><given-names>H</given-names></name><etal/></person-group><article-title>Generalisability of The Health Improvement etwork (THIN) database: demographics, chronic disease prevalence and mortality rates</article-title><source>Inform Prim Care</source><year>2011</year><volume>19</volume><fpage>251</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">22828580</pub-id></element-citation></ref><ref id="b26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tata</surname><given-names>LJ</given-names></name><name><surname>Hubbard</surname><given-names>RB</given-names></name><name><surname>McKeever</surname><given-names>TM</given-names></name><etal/></person-group><article-title>Fertility rates in women with asthma, eczema, and hay fever: a general population-based cohort study</article-title><source>Am J Epidemiol</source><year>2007</year><volume>165</volume><issue>9</issue><fpage>1023</fpage><lpage>1030</lpage><pub-id pub-id-type="pmid">17255115</pub-id></element-citation></ref><ref id="b27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szatkowski</surname><given-names>L</given-names></name><name><surname>Lewis</surname><given-names>S</given-names></name><name><surname>McNeill</surname><given-names>A</given-names></name><etal/></person-group><article-title>Can data from primary care medical records be used to monitor national smoking prevalence?</article-title><source>J Epidemiol Community Health</source><year>2012</year><volume>66</volume><issue>9</issue><fpage>791</fpage><lpage>795</lpage><pub-id pub-id-type="pmid">21571750</pub-id></element-citation></ref><ref id="b28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langley</surname><given-names>TE</given-names></name><name><surname>Szatkowski</surname><given-names>L</given-names></name><name><surname>Wythe</surname><given-names>S</given-names></name><etal/></person-group><article-title>Can primary care data be used to monitor regional smoking prevalence? An analysis of The Health Improvement Network primary care data</article-title><source>BMC Public Health</source><year>2011</year><volume>11</volume><issue>773</issue></element-citation></ref><ref id="b29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Health and Social Care Information Centre</collab></person-group><source>Read Codes</source><comment><ext-link ext-link-type="uri" xlink:href="http://systems.hscic.gov.uk/data/uktc/readcodes">http://systems.hscic.gov.uk/data/uktc/readcodes</ext-link> (accessed 1 Aug 2014)</comment></element-citation></ref><ref id="b30"><label>30.</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Primary Care Commissioning</collab></person-group><comment><ext-link ext-link-type="uri" xlink:href="http://www.pcc-cic.org.uk/search/site/general%20practice%20contracts?f%255b0%255d=im_field_topics%253A52&#x00026;f%255b1%255d=im_field_topics%253A68">http://www.pcc-cic.org.uk/search/site/general%20practice%20contracts?f%255b0%255d=im_field_topics%253A52&#x00026;f%255b1%255d=im_field_topics%253A68</ext-link> (accessed 1 Aug 2014)</comment></element-citation></ref><ref id="b31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhalwani</surname><given-names>NN</given-names></name><name><surname>Tata</surname><given-names>LJ</given-names></name><name><surname>Coleman</surname><given-names>T</given-names></name><etal/></person-group><article-title>Completeness of maternal smoking status recording during pregnancy in United Kingdom primary care data</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><issue>9</issue><fpage>e72218</fpage><pub-id pub-id-type="pmid">24069143</pub-id></element-citation></ref><ref id="b32"><label>32.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Joint Formulary Committee</collab></person-group><source>British National Formulary (BNF)</source><year>2011</year><edition>62nd edn</edition><publisher-loc>London</publisher-loc><publisher-name>BMJ Group and Pharmaceutical Press</publisher-name></element-citation></ref><ref id="b33"><label>33.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Townsend</surname><given-names>P</given-names></name><name><surname>Phillimore</surname><given-names>P</given-names></name><name><surname>Beattie</surname><given-names>A</given-names></name></person-group><source>Health and deprivation: inequality and the North</source><year>1988</year><publisher-loc>London</publisher-loc><publisher-name>Croom Helm</publisher-name></element-citation></ref><ref id="b34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Primatesta</surname><given-names>P</given-names></name><name><surname>Falaschetti</surname><given-names>E</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><etal/></person-group><article-title>Association between smoking and blood pressure evidence from the health survey for England</article-title><source>Hypertension</source><year>2001</year><volume>37</volume><fpage>187</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">11230269</pub-id></element-citation></ref><ref id="b35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiolero</surname><given-names>A</given-names></name><name><surname>Faeh</surname><given-names>D</given-names></name><name><surname>Paccaud</surname><given-names>F</given-names></name><etal/></person-group><article-title>Consequences of smoking for body weight, body fat distribution, and insulin resistance</article-title><source>Am J Clin Nutr</source><year>2008</year><volume>87</volume><issue>4</issue><fpage>801</fpage><lpage>809</lpage><pub-id pub-id-type="pmid">18400700</pub-id></element-citation></ref><ref id="b36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siroux</surname><given-names>V</given-names></name><name><surname>Pin</surname><given-names>I</given-names></name><name><surname>Oryszczyn</surname><given-names>M</given-names></name><etal/></person-group><article-title>Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma</article-title><source>Eur Respir J</source><year>2000</year><volume>15</volume><issue>3</issue><fpage>470</fpage><lpage>477</lpage><pub-id pub-id-type="pmid">10759439</pub-id></element-citation></ref><ref id="b37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lasser</surname><given-names>K</given-names></name><name><surname>Boyd</surname><given-names>JW</given-names></name><name><surname>Woolhandler</surname><given-names>S</given-names></name><etal/></person-group><article-title>Smoking and mental illness</article-title><source>JAMA</source><year>2000</year><volume>284</volume><issue>20</issue><fpage>2606</fpage><lpage>2610</lpage><pub-id pub-id-type="pmid">11086367</pub-id></element-citation></ref><ref id="b38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Will</surname><given-names>JC</given-names></name><name><surname>Galuska</surname><given-names>DA</given-names></name><name><surname>Ford</surname><given-names>ES</given-names></name><etal/></person-group><article-title>Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study</article-title><source>Int J Epidemiol</source><year>2001</year><volume>30</volume><issue>3</issue><fpage>540</fpage><lpage>546</lpage><pub-id pub-id-type="pmid">11416080</pub-id></element-citation></ref><ref id="b39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanley</surname><given-names>JA</given-names></name><name><surname>Negassa</surname><given-names>A</given-names></name><name><surname>Forrester</surname><given-names>JE</given-names></name></person-group><article-title>Statistical analysis of correlated data using generalized estimating equations: an orientation</article-title><source>Am J Epidemiol</source><year>2003</year><volume>157</volume><issue>4</issue><fpage>364</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">12578807</pub-id></element-citation></ref><ref id="b40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fahy</surname><given-names>SJ</given-names></name><name><surname>Cooper</surname><given-names>S</given-names></name><name><surname>Coleman</surname><given-names>T</given-names></name><etal/></person-group><article-title>Provision of smoking cessation support for pregnant women in England: results from an online survey of NHS stop smoking services for pregnant women</article-title><source>BMC Health Serv Res</source><year>2014</year><volume>14</volume><fpage>107</fpage><pub-id pub-id-type="pmid">24593130</pub-id></element-citation></ref><ref id="b41"><label>41.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Afolabi</surname><given-names>AO</given-names></name></person-group><article-title>Self medication, drug dependence and self-managed health care &#x02014; a review</article-title><source>Public health &#x02014; social and behavioural health</source><year>2012</year><publisher-loc>Croatia</publisher-loc><publisher-name>Intech</publisher-name><fpage>223</fpage><lpage>243</lpage></element-citation></ref><ref id="b42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>NHS Choices</collab></person-group><source>Are pregnant women entitled to free NHS prescriptions?</source><comment><ext-link ext-link-type="uri" xlink:href="http://www.nhs.uk/chq/Pages/941.aspx?CategoryID=68&#x00026;SubCategoryID=161#close">http://www.nhs.uk/chq/Pages/941.aspx?CategoryID=68&#x00026;SubCategoryID=161#close</ext-link>. (accessed 9 Jul 2014)</comment></element-citation></ref><ref id="b43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McRobbie</surname><given-names>H</given-names></name><name><surname>Maniapoto</surname><given-names>M</given-names></name></person-group><article-title>Getting the most out of nicotine replacement therapy</article-title><source>Best Practice Journal</source><year>2009</year><volume>20</volume><fpage>58</fpage><lpage>62</lpage></element-citation></ref><ref id="b44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eachus</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>M</given-names></name><name><surname>Chan</surname><given-names>P</given-names></name><etal/></person-group><article-title>Deprivation and cause specific morbidity: evidence from the Somerset and Avon survey of health</article-title><source>BMJ</source><year>1996</year><volume>312</volume><fpage>287</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">8611787</pub-id></element-citation></ref><ref id="b45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>G</given-names></name><name><surname>Thompson</surname><given-names>ME</given-names></name><name><surname>Hall</surname><given-names>GB</given-names></name></person-group><article-title>Pathways of neighbourhood-level socioeconomic determinants of adverse birth outcomes</article-title><source>Int J Health Geographics</source><year>2013</year><volume>12</volume><issue>1</issue><fpage>32</fpage></element-citation></ref><ref id="b46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson-Piercy</surname><given-names>C</given-names></name></person-group><article-title>Asthma in pregnancy</article-title><source>BMJ</source><year>2001</year><volume>56</volume><fpage>325</fpage><lpage>8</lpage></element-citation></ref><ref id="b47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>HA</given-names></name><name><surname>Einarson</surname><given-names>A</given-names></name><name><surname>Taddio</surname><given-names>A</given-names></name><etal/></person-group><article-title>Prevalence of depression during pregnancy: systematic review</article-title><source>Obstet Gynecol</source><year>2004</year><volume>103</volume><issue>4</issue><fpage>698</fpage><lpage>709</lpage><pub-id pub-id-type="pmid">15051562</pub-id></element-citation></ref><ref id="b48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stead</surname><given-names>LF</given-names></name><name><surname>Perera</surname><given-names>R</given-names></name><name><surname>Bullen</surname><given-names>C</given-names></name><etal/></person-group><article-title>Nicotine Replacement Therapy for smoking cessation (Review)</article-title><source>Cochrane Database Syst Rev</source><year>2008</year><issue>1</issue><fpage>CD000146</fpage><pub-id pub-id-type="pmid">18253970</pub-id></element-citation></ref><ref id="b49"><label>49.</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>National Institute for Health and Care Excellence</collab></person-group><source>NICE implementation uptake report: smoking cessation drugs</source><comment><ext-link ext-link-type="uri" xlink:href="https://www.nice.org.uk/proxy/?sourceUrl=http%3a%2f%2fwww.nice.org.uk%2fmedia%2fD79%2f42%2fUptakeReportSmokingCessationPublication.pdf">https://www.nice.org.uk/proxy/?sourceUrl=http%3a%2f%2fwww.nice.org.uk%2fmedia%2fD79%2f42%2fUptakeReportSmokingCessationPublication.pdf</ext-link> (accessed 1 Aug 2014)</comment></element-citation></ref><ref id="b50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klesges</surname><given-names>LM</given-names></name><name><surname>Johnson</surname><given-names>KC</given-names></name><name><surname>Ward</surname><given-names>KD</given-names></name><etal/></person-group><article-title>Smoking cessation in pregnant women</article-title><source>Obstet Gynecol Clin North Am</source><year>2001</year><volume>28</volume><issue>2</issue><fpage>269</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">11430176</pub-id></element-citation></ref></ref-list></back></article>